United States securities and exchange commission logo




                                                                                
                             March 31, 2022

       Jianhui Ye
       Chief Executive Officer
       EZGO Technologies Ltd.
       Building #A, Floor 2
       Changzhou Institute of Dalian University of Technology
       Wujin District, Changzhou City
       Jiangsu, China 213164

                                                        Re: EZGO Technologies 
Ltd.
                                                            Registration 
Statement on Form F-3
                                                            Filed March 4, 2022
                                                            File No. 333-263315

       Dear Mr. Ye:

              We have limited our review of your registration statement to 
those issues we have
       addressed in our comments. In some of our comments, we may ask you to 
provide us with
       information so we may better understand your disclosure.

              Please respond to this letter by amending your registration 
statement and providing the
       requested information. If you do not believe our comments apply to your 
facts and
       circumstances or do not believe an amendment is appropriate, please tell 
us why in your
       response.

              After reviewing any amendment to your registration statement and 
the information you
       provide in response to these comments, we may have additional comments.

       Registration Statement on Form F-3 filed March 4, 2022

       Cover Page

   1.                                                   Please disclose 
prominently on the prospectus cover page that you are not a Chinese
                                                        operating company but a 
British Virgin Islands Islands holding company with operations
                                                        conducted by your 
subsidiaries and through contractual arrangements with a variable
                                                        interest entity (VIE) 
based in China and that this structure involves unique risks to
                                                        investors. If true, 
disclose that the contractual arrangements with your VIE have not been
                                                        tested in court. Also, 
please revise the disclosure in the seventh paragraph of the cover
                                                        page to explain whether 
the VIE structure is used to provide investors with exposure to
                                                        foreign investment in 
China-based companies where Chinese law prohibits direct foreign
 Jianhui Ye
FirstName  LastNameJianhui Ye
EZGO Technologies   Ltd.
Comapany
March      NameEZGO Technologies Ltd.
       31, 2022
March2 31, 2022 Page 2
Page
FirstName LastName
         investment in the operating companies, and disclose that investors may 
never hold equity
         interests in the Chinese operating company. Also, revise the 
disclosure in the seventh
         paragraph to acknowledge that Chinese regulatory authorities could 
disallow this VIE
         structure, which would likely result in a material change in your 
operations and/or a
         material change in the value of the securities you are registering for 
sale, including that it
         could cause the value of such securities to significantly decline or 
become worthless.
         Provide a cross-reference to your detailed discussion of risks facing 
the company and the
         offering as a result of this structure.
2.       We note your disclosure in the seventh paragraph on the cover page 
that you "control and
         receive the economic benefits of the VIE   s business operations 
through certain contractual
         arrangements." Please remove the language that you "control" the VIE's 
business.
3.       Please revise the disclosure in the eighth paragraph on the cover page 
to make clear
         whether the legal and operational risks associated with being based in 
or having the
         majority of the company   s operations in China could result in a 
material change in your
         operations and/or the value of the securities you are registering for 
sale or could
         significantly limit or completely hinder your ability to offer or 
continue to offer securities
         to investors and cause the value of such securities to significantly 
decline or be worthless.
         Also, revise the reference in the fifth sentence to "list on a U.S. 
exchange" to instead refer
         to list on a U.S. or other foreign exchange. Your prospectus summary 
should address, but
         not necessarily be limited to, the risks highlighted on the prospectus 
cover page.
4.       Clearly disclose how you will refer to the holding company, 
subsidiaries, and VIE when
         providing the disclosure throughout the document so that it is clear 
to investors which
         entity the disclosure is referencing and which subsidiaries or 
entities are conducting the
         business operations. Refrain from using terms such as    we    or    
our    when describing
         activities or functions of a VIE. For example, disclose, if true, that 
your subsidiaries
         and/or the VIE conduct operations in China, that the VIE is 
consolidated for accounting
         purposes but is not an entity in which you own equity, and that the 
holding company does
         not conduct operations.
5.       It appears from the disclosure in the last paragraph on page 28 and 
from the disclosure in
         the first paragraph on page 30 of your Annual Report on Form 20-F for 
the fiscal year
         ended September 30, 2021 that there is more than one VIE. Please 
advise or revise.
6.       Provide a description of how cash is transferred through your 
organization. In addition,
         expand disclosure in the last two sentences in the tenth paragraph on 
the cover page to
         disclose your intentions to distribute earnings or settle amounts owed 
under the VIE
         agreements. Also, state whether any transfers, dividends, or 
distributions have been made
         to date between the holding company, its subsidiaries, and 
consolidated VIE, or to
         investors, and quantify the amounts where applicable. In this regard, 
we note the
         disclosure that "To date, there have not been any such dividends or 
other distributions
         from our PRC subsidiaries to our subsidiaries located outside of China 
... as of the date of
         this prospectus, none of our PRC subsidiaries have ever issued any 
dividends or
 Jianhui Ye
FirstName  LastNameJianhui Ye
EZGO Technologies   Ltd.
Comapany
March      NameEZGO Technologies Ltd.
       31, 2022
March3 31, 2022 Page 3
Page
FirstName LastName
         distributions to EZGO or its shareholders outside of China ... as of 
the date of this
         prospectus, neither EZGO nor any of its subsidiaries have ever paid 
dividends or made
         distributions to U.S. investors." Provide cross-references to the 
condensed consolidating
         schedule and the consolidated financial statements.
7.       Please state where you maintain bank accounts and balances. Please 
clarify the amount of
         your cash that is in RMB and Hong Kong dollars. Please disclose 
whether cash generated
         from one subsidiary is used to fund another subsidiary's operations, 
whether your
         subsidiaries have ever faced difficulties or limitations on their 
ability to transfer cash
         between subsidiaries, and whether your subsidiaries have cash 
management policies that
         dictate the amount of such funding. Also, disclose whether your 
subsidiaries have cash
         management policies/procedures that dictate how funds are transferred. 
Your disclosure
         should address the possibility that the PRC could prevent the cash 
maintained in the PRC
         or Hong Kong from leaving, or that the PRC could restrict deployment 
of the cash into
         the business or for the payment of dividends. Add similar disclosure 
to risk factors and to
         the summary of risk factors.
Prospectus Summary, page 1

8.       Please revise the diagram of the corporate structure on page 2 to use 
a dashed line without
         an arrow to depict the relationship with a VIE. Also, revise the 
disclosure on page 3 to
         explain how and why the contractual arrangements may be less effective 
than direct
         ownership.
9.       We note the disclosure on page 5 about the opinion of DeHeng Law 
Offices and
         the references on page 40 to you have been advised by DeHeng Law 
Offices. Please file
         the opinion and counsel's consent as exhibits to the registration 
statement.
10.      Please include in the prospectus summary a new subsection that 
summarizes your risk
         factors. In the summary of risk factors, please disclose the risks 
that your corporate
         structure and being based in or having the majority of the company   s 
operations in China
         poses to investors. In particular, describe the significant 
regulatory, liquidity, and
         enforcement risks with cross-references to the more detailed 
discussion of these risks in
         the prospectus. For example, specifically discuss risks arising from 
the legal system in
         China, including risks and uncertainties regarding the enforcement of 
laws and that rules
         and regulations in China can change quickly with little advance 
notice; and the risk that
         the Chinese government may intervene or influence your operations at 
any time, or may
         exert more control over offerings conducted overseas and/or foreign 
investment in China-
         based issuers, which could result in a material change in your 
operations and/or the value
         of the securities you are registering for sale. Acknowledge any risks 
that any actions by
         the Chinese government to exert more oversight and control over 
offerings that are
         conducted overseas and/or foreign investment in China-based issuers 
could significantly
         limit or completely hinder your ability to offer or continue to offer 
securities to investors
         and cause the value of such securities to significantly decline or be 
worthless.
 Jianhui Ye
FirstName  LastNameJianhui Ye
EZGO Technologies   Ltd.
Comapany
March      NameEZGO Technologies Ltd.
       31, 2022
March4 31, 2022 Page 4
Page
FirstName LastName
11.      We note that the consolidated VIE constitutes a material part of your 
consolidated
         financial statements. Please provide in tabular form a condensed 
consolidating schedule
         that disaggregates the operations and depicts the financial position, 
cash flows, and results
         of operations as of the same dates and for the same periods for which 
audited consolidated
         financial statements are required. The schedule should present major 
line items, such as
         revenue and cost of goods/services, and subtotals and disaggregated 
intercompany
         amounts, such as separate line items for intercompany receivables and 
investment in
         subsidiary. The schedule should also disaggregate the parent company, 
the VIE and its
         consolidated subsidiaries, the WFOEs that are the primary beneficiary 
of the VIE, and an
         aggregation of other entities that are consolidated. The objective of 
this disclosure is to
         allow an investor to evaluate the nature of assets held by, and the 
operations of, entities
         apart from the VIE, as well as the nature and amounts associated with 
intercompany
         transactions. Any intercompany amounts should be presented on a gross 
basis and when
         necessary, additional disclosure about such amounts should be included 
in order to make
         the information presented not misleading.
12.      We note your disclosure in the "Transfer of Cash through our 
Organization" on page 8.
         Provide a clear description of how cash is transferred through your 
organization. Disclose
         your intentions to distribute earnings or settle amounts owed under 
the VIE agreements.
         Quantify any cash flows and transfers of other assets by type that 
have occurred between
         the holding company, its subsidiaries, and the consolidated VIE, and 
direction of transfer.
         Quantify any dividends or distributions that a subsidiary or 
consolidated VIE have made
         to the holding company and which entity made such transfer, and their 
tax consequences.
         Similarly quantify dividends or distributions made to U.S. investors, 
the source, and their
         tax consequences. Your disclosure should make clear if no transfers, 
dividends, or
         distributions have been made to date. Describe any restrictions on 
foreign exchange and
         your ability to transfer cash between entities, across borders, and to 
U.S. investors.
         Describe any restrictions and limitations on your ability to 
distribute earnings from the
         company, including your subsidiaries and/or the consolidated VIE, to 
the parent company
         and U.S. investors as well as the ability to settle amounts owed under 
the VIE
         agreements.
13.      We note your disclosure on page 12 that "no relevant laws or 
regulations in the PRC
         explicitly require us to seek approval ... authorities." Please revise 
your prospectus
         summary in accordance with comment number 8 of the Staff's "Sample 
Letter to China
         Based Companies" published on December 20, 2021. Please revise to 
disclose each
         permission or approval that you, your subsidiaries, or the VIE are 
required to obtain from
         Chinese authorities to operate your business and to offer the 
securities being registered to
         foreign investors. State whether you, your subsidiaries, or VIE are 
covered by permissions
         requirements from the China Securities Regulatory Commission (CSRC), 
Cyberspace
         Administration of China (CAC) or any other governmental agency that is 
required to
         approve the VIE   s operations, and state affirmatively whether you 
have received all
         requisite permissions or approvals and whether any permissions or 
approvals have been
         denied. Please also describe the consequences to you and your 
investors if you, your
 Jianhui Ye
FirstName  LastNameJianhui Ye
EZGO Technologies   Ltd.
Comapany
March      NameEZGO Technologies Ltd.
       31, 2022
March5 31, 2022 Page 5
Page
FirstName LastName
         subsidiaries, or the VIE: (i) do not receive or maintain such 
permissions or approvals, (ii)
         inadvertently conclude that such permissions or approvals are not 
required, or (iii)
         applicable laws, regulations, or interpretations change and you are 
required to obtain such
         permissions or approvals in the future.
14.      We note the disclosure on page 12 that "we are relying on an opinion 
of our PRC
         counsel." Please revise the disclosure to identify counsel and file an 
exhibit.
15.      Disclose that trading in your securities may be prohibited under the 
Holding Foreign
         Companies Accountable Act if the PCAOB determines that it cannot 
inspect or investigate
         completely your auditor, and that as a result an exchange may 
determine to delist your
         securities. Disclose whether your auditor is subject to the 
determinations announced by
         the PCAOB on December 16, 2021.
16.      We note the the references to "cause our Ordinary Shares to 
significantly decline" and
         "continue to offer our Ordinary Shares" on page 12. Please revise your 
disclosure and
         make conforming changes throughout the prospectus to clarify that the 
references apply to
         the value of the securities you are registering for sale, as we note 
that you are registering
         not only ordinary shares but also preferred shares, debt securities, 
warrants, rights and
         units. Please make conforming changes in each appropriate instance 
throughout the
         prospectus.
Risk Factors, page 14

17.      Notwithstanding your reference on the cover page to a description of 
your corporate
         structure and VIE contractual arrangements in Item 3.D of your Form 
20-F for the fiscal
         year ended September 30, 2021, please revise your risk factor 
disclosure in the prospectus
         to address our comments. Revise your risk factors to acknowledge that 
if the PRC
         government determines that the contractual arrangements constituting 
part of the VIE
         structure do not comply with PRC regulations, or if these regulations 
change or are
         interpreted differently in the future, the securities you are 
registering may decline in value
         or become worthless if the determinations, changes, or interpretations 
result in your
         inability to assert contractual control over the assets of your PRC 
subsidiaries or the
         VIE that conducts all or substantially all of your operations.
18.      Notwithstanding the risk factors in your Form 20-F for the fiscal year 
ended September
         30, 2021, please revise your risk factor disclosure in the prospectus 
to address our
         comments. Given the Chinese government   s significant oversight and 
discretion over the
         conduct of your business, please revise your prospectus to highlight 
separately the risk
         that the Chinese government may intervene or influence your operations 
at any time,
         which could result in a material change in your operations and/or the 
value of the
         securities you are registering. Also, given recent statements by the 
Chinese government
         indicating an intent to exert more oversight and control over 
offerings that are conducted
         overseas and/or foreign investment in China-based issuers, acknowledge 
the risk that any
         such action could significantly limit or completely hinder your 
ability to offer or continue
 Jianhui Ye
EZGO Technologies Ltd.
March 31, 2022
Page 6
      to offer securities to investors and cause the value of such securities 
to significantly
      decline or be worthless.
19.   In light of recent events indicating greater oversight by the Cyberspace 
Administration of
      China (CAC) over data security, particularly for companies seeking to 
list on a foreign
      exchange, please revise your disclosure to explain how this oversight 
impacts your
      business and your offering and to what extent you believe you are 
compliant with the
      regulations or policies that have been issued by the CAC to date.
The PRC government exerts substantial influence over the manner in which we 
conduct our
business, page 16

20.   We note the disclosure in the first and last paragraphs of this risk 
factor that "We are
      currently not required to obtain approval from Chinese authorities for 
listing on U.S.
      exchanges, nor the execution of the VIE Agreements" and "we are currently 
not required
      to obtain permission from any of the PRC central or local government," 
respectively.
      Please explain how you determined whether any permissions or approvals 
were not
      required. If you relied on counsel, identify counsel and file an exhibit.
Our Ordinary Shares may be delisted under the Holding Foreign Companies 
Accountable Act,
page 27

21.   Please revise the disclosure in the first paragraph on page 28 to clarify 
that the United
      States Senate has passed the Accelerating Holding Foreign Companies 
Accountable Act,
      which, if enacted, would decrease the number of "non-inspection years" 
from three years
      to two years, and thus, would reduce the time before your securities may 
be prohibited
      from trading or delisted. Please revise the disclosure in the second 
paragraph on page 28
      to reflect that the Commission adopted rules to implement the HFCAA and 
that, pursuant
      to the HFCAA, the PCAOB has issued its report notifying the Commission of 
its
      determination that it is unable to inspect or investigate completely 
accounting firms
      headquartered in mainland China or Hong Kong.
      You may contact Thomas Jones, Staff Attorney, at 202-551-3602 or Erin 
Purnell, Legal
Branch Chief, at 202-551-3454 with any questions.



                                                              Sincerely,
FirstName LastNameJianhui Ye
                                                              Division of 
Corporation Finance
Comapany NameEZGO Technologies Ltd.
                                                              Office of 
Manufacturing
March 31, 2022 Page 6
cc:       Richard I. Anslow, Esq.
FirstName LastName